{"result": "(\"entity\"<|>MECV-V<|>ORGANIZATION<|>The MECV-V is a clinical method for assessing swallowing safety and efficacy in patients with suspected swallowing disorders.)\n##\n(\"entity\"<|>DAVID G SMITHARD<|>PERSON<|>David G Smithard is a professional who initially designed the Standardized Bedside Swallowing Assessment (SSA) for detecting swallowing disorders.)\n##\n(\"entity\"<|>RASEMARY WYATT<|>PERSON<|>Rasemary Wyatt is a professional who collaborated with David G Smithard in designing the Standardized Bedside Swallowing Assessment (SSA).)\n##\n(\"entity\"<|>STANDARDIZED BEDSIDE SWALLOWING ASSESSMENT<|>EVENT<|>The Standardized Bedside Swallowing Assessment (SSA) is a tool used for the detection of swallowing disorders, particularly in patients with acute neurological conditions.)\n##\n(\"entity\"<|>DOF<|>EVENT<|>DOF refers to oropharyngeal dysphagia, a condition that affects swallowing.)\n##\n(\"entity\"<|>FIBROENDOSCOPIC EVALUATION OF SWALLOWING<|>EVENT<|>Fiberoptic Endoscopic Evaluation of Swallowing (FEES) is an instrumental test used to study swallowing disorders.)\n##\n(\"entity\"<|>VIDEOFLOUROSCOPY<|>EVENT<|>Videofluoroscopy is a diagnostic procedure that uses X-ray technology to visualize swallowing.)\n##\n(\"entity\"<|>CLINICAL EXPLORATION METHOD<|>EVENT<|>The clinical exploration method volume-viscosity is used to assess swallowing progress and safety in patients.)\n##\n(\"relationship\"<|>DAVID G SMITHARD<|>STANDARDIZED BEDSIDE SWALLOWING ASSESSMENT<|>David G Smithard designed the SSA to help detect swallowing disorders<|>8)\n##\n(\"relationship\"<|>RASEMARY WYATT<|>STANDARDIZED BEDSIDE SWALLOWING ASSESSMENT<|>Rasemary Wyatt collaborated with David G Smithard in the design of the SSA<|>8)\n##\n(\"relationship\"<|>MECV-V<|>DOF<|>The MECV-V method is indicated for patients with suspected DOF<|>7)\n##\n(\"relationship\"<|>STANDARDIZED BEDSIDE SWALLOWING ASSESSMENT<|>DOF<|>The SSA is used to detect DOF in patients<|>7)\n##\n(\"relationship\"<|>MECV-V<|>FIBROENDOSCOPIC EVALUATION OF SWALLOWING<|>The MECV-V method helps determine which patients should undergo FEES<|>6)\n##\n(\"relationship\"<|>MECV-V<|>VIDEOFLOUROSCOPY<|>The MECV-V method helps decide which patients should be evaluated with videofluoroscopy<|>6)\n##\n(\"relationship\"<|>MECV-V<|>CLINICAL EXPLORATION METHOD<|>The MECV-V method is a clinical exploration method for assessing swallowing<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: la voz y desaturación de oxígeno) y en los signos de eficacia de la deglución\n          (sello labial, residuo oral, deglución fraccionada y residuo faríngeo).\n               La pueba comienza ofreciendo el bolo de menor volumen (5 ml) con viscosidad\n          néctar, y se aumenta la cantidad a 10 y 20 ml si el paciente no manifiesta alteraciones\n          en los signos de seguridad de la deglución.\n               Si el paciente ingiere sin alteraciones los tres bolos con vicosidad néctar, se\n          continúa la prueba con viscosidad líquida, comenzando por el volumen de 5 ml. Si,\n          por el contrario, el paciente manifiesta alteraciones en los signos de seguridad con\n          la viscosidad néctar, se ofrecerá el bolo más bajo de la viscosidad pudin. Durante la\n          prueba, el paciente debe monitorizarse mediate pulsioxímetro, con el fin de detectar\n          las aspiraciones silentes (Figs. 1 y 2).\n                 Viscosidad                 Nectar                     Liquido                     Pudin\n                  Volumen           5 ml    10 ml    20 ml     5 ml     10 ml    20 ml     5 ml     10 ml  20 ml\n             Signos de seguridad\n            Voz humeda\n            Disfonia\n            Desaturacion de Oxigero\n             Signos de eficacia\n            Scllo labial\n            Residuns orales\n             Carrasped\n            Deglucion Iraccicnada\n             Figura 1. Hoja de registro del MECV-V. Modificado de P. Clavé et al1 .\n\n\n\n30\n---\n                                                            2. Métodos de cribado para la disfagia orofaríngea\n\n\n\n                                  Técnica del MECV-V\n        • Secuencia de la prueba:\n                            CON ALTERACIÓN\n                            EN LA SEGURIDAD\n\n\n\n            - Néctar: 5 ml → 10 ml → 20 ml\n\n\n\n            - Agua: 5 ml → 10 ml → 20 ml\n\n\n\n            - Pudin: 5 ml → 10 ml → 20 ml\n\n\n\n        • Detección de signos de alteración de la seguridad y de\n          la eficacia en cada bolo.\n        Figura 2. Flujo de MECV-V. Modificado de P. Clavé et al1.\n\n\n\n        Este método de exploración está indicado en cualquier paciente con sospecha de\n    DOF o vulnerable en el riesgo de presentar un trastorno de la deglución, y se puede\n    realizar tanto a la cabecera de la cama, como en la consulta o centros de larga estan-\n    cia, y cuantas veces se crea necesario.\n        El MECV-V no solo indica las alteraciones en la seguridad y la eficacia de la deglu-\n    ción, sino que orienta sobre la modificación en la viscosidad de los líquidos y sobre\n    el volumen que ha de ofrecese al paciente para obtener una deglucíon segura y\n    eficaz. También es últil como criterio de selección para decidir sobre qué pacientes\n    deben estudiarse con pruebas instrumentales como la fibroendoscopia de la deglu-\n    ción (FEES, Fiberoptic Endoscopic Evaluation of Swallowing) o la videofluoroscopia. El\n    método de exploración clínica volumen-viscosidad es un buen método para valorar\n    los progresos de la terapia rehabilitadora de la deglución. En manos de profesionales\n    formados y entrenados, la sensibilidad diagnóstica de este método para detectar\n    alteraciones en la seguridad es del 88,1%, y para la eficacia, del 89,9%.\n\n\n\n31\n---\n MANUAL DE DISFAGIA OROFARÍNGEA: SOLUCIONES MULTIDISCIPLINARES\n\n\n\n         ◗ 3.2. Standardized Bedside Swallowing Assessment (SSA)\n             El SSA se diseñó inicialmente por David G Smithard y Rasemary Wyatt para utili-\n         zarse como una herramienta fácil por profesionales no expertos en disfagia para la\n         detección de la DOF.\n             Consta de varias etapas; la primera consiste en hacer una evaluación general del\n         paciente: nivel de consciencia, control postural, tos voluntaria, calidad de la voz y\n         capacidad de tragar su propia saliva, dándole agua a volúmenes pequeños con una\n         cuchara, si el paciente no presenta alteraciones, se le da de beber agua en un vaso.\n             Se registran las alteraciones de los signos clínicos (tos, babeo, desaturación de\n         oxígeno, cambios de la calidad de la voz) y se emite un juicio global sobre la seguri-\n         dad de la deglución el paciente. Se utiliza sobre todo en pacientes con enfermedad\n         neurológica aguda.\n             El uso del SSA para la detección de aspiración silente muestra una sensibilidad\n         variable (47% a 68%) y una especificidad (67% a 86\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}